Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A2A and Dual A1/A2A Receptor Affinity
Authors:
- Michał ZałuskiMZMichał Załuski
- Dorota ŁażewskaDŁDorota Łażewska
- Piotr JaśkoPJPiotr Jaśko
- Ewelina Honkisz-OrzechowskaEHEwelina Honkisz-Orzechowska
- Kamil J. KuderKKKamil J. Kuder
- Andreas BrockmannABAndreas Brockmann
- Gniewomir LataczGLGniewomir Latacz
- Małgorzata ZygmuntMZMałgorzata Zygmunt
- Maria KaletaMKMaria Kaleta
- Beril Anita GreserBGBeril Anita Greser
- Agnieszka Olejarz-MaciejAOAgnieszka Olejarz-Maciej
- Magdalena Jastrzębska-WięsekMJMagdalena Jastrzębska-Więsek
Open Access
- 5 September 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (18) , 13707
Abstract
Chronic inflammation plays an important role in the development of neurodegenerative diseases, such as Parkinson’s disease (PD). In the present study, we synthesized 25 novel xanthine derivatives with variable substituents at the N1-, N3- and C8-position as adenosine receptor antagonists with potential anti-inflammatory activity. The compounds were investigated in radioligand binding studies at all four human adenosine receptor subtypes, A1, A2A, A2B and A3. Compounds showing nanomolar A2A and dual A1/A2A affinities were obtained. Three compounds, 19, 22 and 24, were selected for further studies. Docking and molecular dynamics simulation studies indicated binding poses and interactions within the orthosteric site of adenosine A1 and A2A receptors. In vitro studies confirmed the high metabolic stability of the compounds, and the absence of toxicity at concentrations of up to 12.5 µM in various cell lines (SH-SY5Y, HepG2 and BV2). Compounds 19 and 22 showed anti-inflammatory activity in vitro. In vivo studies in mice investigating carrageenan- and formalin-induced inflammation identified compound 24 as the most potent anti-inflammatory derivative. Future studies are warranted to further optimize the compounds and to explore their therapeutic potential in neurodegenerative diseases.Keywords
Funding Information
- Jagiellonian University Medical College in Krakow (N42/DBS/000333)
This publication has 41 references indexed in Scilit:
- Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinedionesPurinergic Signalling, 2013
- Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunctionJournal of Neurochemistry, 2011
- ConfGen: A Conformational Search Method for Efficient Generation of Bioactive ConformersJournal of Chemical Information and Modeling, 2010
- Improving Potency, Selectivity, and Water Solubility of Adenosine A1Receptor Antagonists: Xanthines Modified at Position 3 and Related Pyrimido[1,2,3‐cd]purinedionesChemMedChem, 2006
- OPM: Orientations of Proteins in Membranes databaseBioinformatics, 2006
- A hierarchical approach to all‐atom protein loop predictionProteins: Structure, Function, and Bioinformatics, 2004
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking AccuracyJournal of Medicinal Chemistry, 2004
- Carrageenan-Induced Paw Edema in the Rat and Mouse2003
- SCH 58261: A selective A2A adenosine receptor antagonistsDrug Development Research, 1997
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983